Search research articles
Contact Us
Filters
Showing results (21-30 of 110) with videos related to
Page
of 11
Sort By:
Future Medicinal Chemistry
|
March 24, 2011
Authentic HIV-1 integrase inhibitors
Chenzhong Liao, Christophe Marchand, Terrence R Burke, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 28, 2007
Virtual screening application of a model of full-length HIV-1 integrase complexed with viral DNA
Chenzhong Liao, Rajeshri G Karki, Christophe Marchand, et al.
Bioorganic & Medicinal Chemistry
|
June 17, 2009
Diketoacid-genre HIV-1 integrase inhibitors containing enantiomeric arylamide functionality
Xue Zhi Zhao, Kasthuraiah Maddali, Christophe Marchand, et al.
Biochemistry
|
March 26, 2010
Biochemical and pharmacological analyses of HIV-1 integrase flexible loop mutants resistant to raltegravir
Mathieu Métifiot, Kasthuraiah Maddali, Alena Naumova, et al.
Journal of Medicinal Chemistry
|
February 25, 2016
Isoquinoline-1,3-diones as Selective Inhibitors of Tyrosyl DNA Phosphodiesterase II (TDP2)
Jayakanth Kankanala, Christophe Marchand, Monica Abdelmalak, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 16, 2004
Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin
Krzysztof Krajewski, Christophe Marchand, Ya-Qiu Long, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 3, 2003
Design and synthesis of dimeric HIV-1 integrase inhibitory peptides
Krzysztof Krajewski, Ya-Qiu Long, Christophe Marchand, et al.
Journal of Medicinal Chemistry
|
March 27, 2015
Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)-tyrosyl-DNA phosphodiesterase I (TDP1) inhibitors
Trung Xuan Nguyen, Monica Abdelmalak, Christophe Marchand, et al.
Journal of Medicinal Chemistry
|
February 13, 2014
Synthesis and biological evaluation of new carbohydrate-substituted indenoisoquinoline topoisomerase I inhibitors and improved syntheses of the experimental anticancer agents indotecan (LMP400) and indimitecan (LMP776)
Daniel E Beck, Keli Agama, Christophe Marchand, et al.
DNA Repair
|
May 11, 2018
Probing the evolutionary conserved residues Y204, F259, S400 and W590 that shape the catalytic groove of human TDP1 for 3'- and 5'-phosphodiester-DNA bond cleavage
Evgeny Kiselev, Thomas S Dexheimer, Christophe Marchand, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 110) with videos related to
Sort By:
Page
of 11
Future Medicinal Chemistry
|
March 24, 2011
Authentic HIV-1 integrase inhibitors
Chenzhong Liao, Christophe Marchand, Terrence R Burke, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 28, 2007
Virtual screening application of a model of full-length HIV-1 integrase complexed with viral DNA
Chenzhong Liao, Rajeshri G Karki, Christophe Marchand, et al.
Bioorganic & Medicinal Chemistry
|
June 17, 2009
Diketoacid-genre HIV-1 integrase inhibitors containing enantiomeric arylamide functionality
Xue Zhi Zhao, Kasthuraiah Maddali, Christophe Marchand, et al.
Biochemistry
|
March 26, 2010
Biochemical and pharmacological analyses of HIV-1 integrase flexible loop mutants resistant to raltegravir
Mathieu Métifiot, Kasthuraiah Maddali, Alena Naumova, et al.
Journal of Medicinal Chemistry
|
February 25, 2016
Isoquinoline-1,3-diones as Selective Inhibitors of Tyrosyl DNA Phosphodiesterase II (TDP2)
Jayakanth Kankanala, Christophe Marchand, Monica Abdelmalak, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 16, 2004
Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin
Krzysztof Krajewski, Christophe Marchand, Ya-Qiu Long, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 3, 2003
Design and synthesis of dimeric HIV-1 integrase inhibitory peptides
Krzysztof Krajewski, Ya-Qiu Long, Christophe Marchand, et al.
Journal of Medicinal Chemistry
|
March 27, 2015
Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)-tyrosyl-DNA phosphodiesterase I (TDP1) inhibitors
Trung Xuan Nguyen, Monica Abdelmalak, Christophe Marchand, et al.
Journal of Medicinal Chemistry
|
February 13, 2014
Synthesis and biological evaluation of new carbohydrate-substituted indenoisoquinoline topoisomerase I inhibitors and improved syntheses of the experimental anticancer agents indotecan (LMP400) and indimitecan (LMP776)
Daniel E Beck, Keli Agama, Christophe Marchand, et al.
DNA Repair
|
May 11, 2018
Probing the evolutionary conserved residues Y204, F259, S400 and W590 that shape the catalytic groove of human TDP1 for 3'- and 5'-phosphodiester-DNA bond cleavage
Evgeny Kiselev, Thomas S Dexheimer, Christophe Marchand, et al.
Page
of 11